Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: a new opportunity for treating activated T cell-driven disease.

Akiyoshi H, Chung JS, Tomihari M, Cruz PD Jr, Ariizumi K.

J Immunol. 2010 Apr 1;184(7):3554-61. doi: 10.4049/jimmunol.0903250. Epub 2010 Feb 22.

2.

Activation-induced accumulation of B and T lymphocyte attenuator at the immunological synapse in CD4+ T cells.

Owada T, Watanabe N, Oki M, Oya Y, Saito Y, Saito T, Iwamoto I, Murphy TL, Murphy KM, Nakajima H.

J Leukoc Biol. 2010 Mar;87(3):425-32. doi: 10.1189/jlb.0309138. Epub 2009 Nov 5.

3.

The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses.

Chung JS, Bonkobara M, Tomihari M, Cruz PD Jr, Ariizumi K.

Eur J Immunol. 2009 Apr;39(4):965-74. doi: 10.1002/eji.200838990.

4.

Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability.

Pentcheva-Hoang T, Chen L, Pardoll DM, Allison JP.

Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17765-70. Epub 2007 Oct 29.

5.

Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation.

Chung JS, Dougherty I, Cruz PD Jr, Ariizumi K.

J Immunol. 2007 Nov 1;179(9):5778-84.

6.

DC-HIL is a negative regulator of T lymphocyte activation.

Chung JS, Sato K, Dougherty II, Cruz PD Jr, Ariizumi K.

Blood. 2007 May 15;109(10):4320-7. Epub 2007 Feb 6.

7.

Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses.

Sato K, Yang XL, Yudate T, Chung JS, Wu J, Luby-Phelps K, Kimberly RP, Underhill D, Cruz PD Jr, Ariizumi K.

J Biol Chem. 2006 Dec 15;281(50):38854-66. Epub 2006 Oct 18.

8.

A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis.

Takahashi T, Takahashi K, Mernaugh RL, Tsuboi N, Liu H, Daniel TO.

Blood. 2006 Aug 15;108(4):1234-42. Epub 2006 Apr 4.

10.
11.

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.

Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, Murphy TL, Russell JH, Allison JP, Murphy KM.

Nat Immunol. 2003 Jul;4(7):670-9. Epub 2003 Jun 8.

PMID:
12796776
12.

New regulatory co-receptors: inducible co-stimulator and PD-1.

Okazaki T, Iwai Y, Honjo T.

Curr Opin Immunol. 2002 Dec;14(6):779-82. Review.

PMID:
12413529
13.

The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn).

Holsinger LJ, Ward K, Duffield B, Zachwieja J, Jallal B.

Oncogene. 2002 Oct 10;21(46):7067-76.

14.
15.

Rat protein tyrosine phosphatase eta physically interacts with the PDZ domains of syntenin.

Iuliano R, Trapasso F, Samà I, Le Pera I, Martelli ML, Lembo F, Santoro M, Viglietto G, Chiariotti L, Fusco A.

FEBS Lett. 2001 Jun 29;500(1-2):41-4.

17.

Negative regulation of human T cell activation by the receptor-type protein tyrosine phosphatase CD148.

Tangye SG, Wu J, Aversa G, de Vries JE, Lanier LL, Phillips JH.

J Immunol. 1998 Oct 15;161(8):3803-7.

18.

CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation.

Tangye SG, Phillips JH, Lanier LL, de Vries JE, Aversa G.

J Immunol. 1998 Oct 1;161(7):3249-55.

19.

Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.

Grootjans JJ, Zimmermann P, Reekmans G, Smets A, Degeest G, Dürr J, David G.

Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13683-8.

20.

CTLA-4 can function as a negative regulator of T cell activation.

Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA.

Immunity. 1994 Aug;1(5):405-13.

PMID:
7882171

Supplemental Content

Support Center